Cytokinetics is a late-stage biopharmaceutical company headquartered in South San Francisco, California. The company is focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors aimed at treating diseases associated with impaired muscle function.
Focus Areas
Notable Investments
